Tr1X, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis (NCT07477639) | Tr1X, Inc. | 2026-03-01 |
| Treatment of Moderate to Severe Refractory Crohn's Disease (NCT06721962) | Tr1X, Inc. | 2025-05-05 |
| Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) (NCT06462365) | Tr1X, Inc. | 2024-04-08 |
Track Tr1X, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.